BIOCELTIX S.A. ZY -10 (XI3) — Cash Flow-to-Debt Ratio
BIOCELTIX S.A. ZY -10 (XI3) has a Cash Flow-to-Debt Ratio of -1.93x as of December 2025, meaning its operating cash flow of €-4.54 Million could theoretically repay -2% of its total liabilities (€2.36 Million) in one year. See XI3 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BIOCELTIX S.A. ZY -10 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for BIOCELTIX S.A. ZY -10 across 5 annual periods. Also explore net asset growth rate of BIOCELTIX S.A. ZY -10 to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BIOCELTIX S.A. ZY -10 (2021–2025)
Year-by-year debt coverage analysis for BIOCELTIX S.A. ZY -10. For market capitalisation and broader financial context, see BIOCELTIX S.A. ZY -10 (XI3) total market value.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.07x | €-11.95 Million | €2.36 Million | ▲ +0.8% |
| 2024 | -5.11x | €-17.57 Million | €3.44 Million | ▲ +21.4% |
| 2023 | -6.50x | €-14.75 Million | €2.27 Million | ▼ -106.6% |
| 2022 | -3.15x | €-7.87 Million | €2.50 Million | ▼ -72.0% |
| 2021 | -1.83x | €-4.02 Million | €2.20 Million | — |